Bavarian Nordic Logo

Bavarian Nordic

A biotech firm developing and manufacturing life-saving vaccines for travel and public health.

BAVA | CO

Overview

Corporate Details

ISIN(s):
DK0015998017 (+1 more)
LEI:
2138006JCDVYIN6INP51
Country:
Denmark
Address:
PHILIP HEYMANS ALLE 3, 2900 HELLERUP
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bavarian Nordic is a fully integrated biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The company specializes in preventing infectious diseases through innovative vaccine technologies. It serves as a leading global provider of travel vaccines and is a key partner for governments and international organizations in delivering public health solutions. Bavarian Nordic manages the entire product lifecycle, from initial research and development through to large-scale manufacturing and distribution.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 14:07
M&A Activity
English 148.1 KB
2025-10-31 14:07
M&A Activity
Danish 19.9 KB
2025-10-31 14:07
M&A Activity
English 158.1 KB
2025-10-31 14:07
M&A Activity
Danish 173.8 KB
2025-10-31 14:07
M&A Activity
English 19.2 KB
2025-10-31 14:07
M&A Activity
Danish 136.4 KB
2025-10-31 09:14
Regulatory News Service
English 7.7 KB
2025-10-31 09:14
Regulatory News Service
Danish 7.0 KB
2025-10-31 09:14
Regulatory News Service
Danish 185.5 KB
2025-10-31 09:14
Regulatory News Service
English 167.0 KB
2025-10-29 13:29
Major Shareholding Notification
Danish 112.2 KB
2025-10-29 13:29
Major Shareholding Notification
English 2.9 KB
2025-10-29 13:29
Major Shareholding Notification
English 188.3 KB
2025-10-29 13:29
Major Shareholding Notification
Danish 2.8 KB
2025-10-21 14:46
M&A Activity
Danish 175.9 KB

Automate Your Workflow. Get a real-time feed of all Bavarian Nordic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bavarian Nordic

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bavarian Nordic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Orion Oyj Logo
Develops and manufactures human/vet pharma, APIs, and generics for global markets.
Finland ORNAV
Orum Therapeutics, Inc. Logo
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
South Korea 475830
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan 4578
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland OVXA
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A former biopharma firm that developed non-addictive, cannabinoid-based pain therapies.
United Kingdom OCTHF
PAION AG Logo
Developed drugs for hospital-based sedation, anesthesia, and critical care.
Germany PA8
Pangen Biotech Inc. Logo
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
South Korea 222110
Pentixapharm Holding AG Logo
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany PTP
PeopleBio, Inc. Logo
Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.
South Korea 304840

Talk to a Data Expert

Have a question? We'll get back to you promptly.